MET and lung cancer: According to these findings, miR-27a could down-regulate MET and EGFR by targeting their 3′ UTRs directly or indirectly through Sprouty2; consequently, the underlying mechanism of the MET and EGFR axis regulation may emerge as new strategies in lung cancer treatment [52,53].